...not a cause for industry reluctance. He said the company's latest IND, through its subsidiary Cell Cure Neurosciences Ltd....

...early next year. Cell Cure is majority-owned by BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX, Alameda, Calif.). Cell Cure Neurosciences Ltd....

...BioTime will purchase 87,456 shares of its Cell Cure NeuroSciences Ltd. subsidiary in exchange for 906,735 BioTime shares at...

...therefore eligible to share in milestones received by Cell Cure. Further terms were not disclosed. Cell Cure Neurosciences Ltd....

...Parkinson's disease (PD). Allon Therapeutics Inc . (TSX:NPC), Vancouver, B.C Amicus Therapeutics Inc., Cranbury, N.J. Cell Cure Neurosciences Ltd....